Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00535-004-1438-2 | DOI Listing |
Clin Gastroenterol Hepatol
May 2017
Division of Gastroenterology, Vancouver General Hospital, University of British Columbia, Vancouver, Canada.
JOP
November 2014
Department of Gastrointestinal Surgery, Nottingham Digestive Diseases Centre National Institute of Health Research Biomedical Research Unit, Nottingham University Hospitals NHS Trust, Queen's Medical Centre. Nottingham, UK.
Context: Gastrointestinal (GI) involvement is present in about one quarter of cases of neurofibromatosis type 1 (NF1). Adenocarcinomas have been reported in several organs. Gastrointestinal stromal tumors are the most common GI lesion seen in NFI.
View Article and Find Full Text PDFJ Med Case Rep
April 2013
General Surgery Department, Istanbul Education and Research Hospital, Org, Abdurrahman Nafiz Gurman Street, Fatih Istanbul, 34096, Turkey.
Introduction: About 70% of well-differentiated endocrine tumors arise from the gastrointestinal tract. Duodenal well-differentiated endocrine tumors account for only 2.6% of all neuroendocrine tumors.
View Article and Find Full Text PDFCrit Rev Oncol Hematol
May 2013
Cukurova University Medical Faculty, Department of Medical Oncology, Adana, Turkey.
Background: Neurofibromatosis type 1 (NF1) is a genetic syndrome that predisposes patients to benign and malignant tumor development. Patients with NF1 develop multiple neurofibromas that can transform into aggressive sarcomas known as malignant peripheral nerve sheath tumors. In contrast, malignant tumors unrelated to the nervous system rarely coexist with neurofibromatosis.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!